Stella Pharma (TSE:4888) Inventories, Raw Materials & Components: 円19.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4888 Stella Pharma Corp TSE:4888
74 GF Score
Price 円337.00
GF Value 円337.87
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Stella Pharma Inventories, Raw Materials & Components?

Stella Pharma TSE:4888 +3.69% 74 Inventories, Raw Materials & Components is 円19.6 Mil as of Mar. 2026. GuruFocus rates TSE:4888 with a GF Score™ of 74/100 and a GF Value™ of 円337.87 (Fairly Valued). The stock has 4 warning signs investors should review.

Stella Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2026 was 円19.6 Mil.

Stella Pharma's quarterly raw materials increased from Mar. 2025 (円2.9 Mil) to Sep. 2025 (円33.4 Mil) but then declined from Sep. 2025 (円33.4 Mil) to Mar. 2026 (円19.6 Mil).

Stella Pharma's annual raw materials declined from Mar. 2024 (円3.0 Mil) to Mar. 2025 (円2.9 Mil) but then increased from Mar. 2025 (円2.9 Mil) to Mar. 2026 (円19.6 Mil).

Stella Pharma Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Stella Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stella Pharma Inventories, Raw Materials & Components Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 1.86 2.19 2.99 2.93 19.62

Stella Pharma Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 2.92 2.93 33.39 19.62
TSE:4888
74GF Score
Stella Pharma Corp TSE:4888
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stella Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円19.6 Mil mean?
Stella Pharma (TSE:4888) has a Inventories, Raw Materials & Components of 円19.6 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Stella Pharma and its competitors.
Is Stella Pharma's Inventories, Raw Materials & Components too high?
Stella Pharma's current Inventories, Raw Materials & Components is 円19.6 Mil. Overall, Stella Pharma has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stella Pharma's Inventories, Raw Materials & Components compare to VRTX and REGN?
Stella Pharma's Inventories, Raw Materials & Components of 円19.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Stella Pharma and its competitors. Stella Pharma's current Inventories, Raw Materials & Components is 円19.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stella Pharma stock overvalued right now?
Based on GuruFocus' analysis, Stella Pharma (TSE:4888) is currently considered Fairly Valued. The stock's GF Value™ is 円337.87, compared to a current price of 円337.00 — trading 0.3% below its estimated fair value. The current Inventories, Raw Materials & Components is 円19.6 Mil. Stella Pharma's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Stella Pharma (TSE:4888), the current Inventories, Raw Materials & Components is 円19.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stella Pharma (TSE:4888) Overvalued in 2026?

Based on GuruFocus' analysis, Stella Pharma stock appears to be undervalued. The current stock price of 円337.00 is trading 0.3% below its estimated GF Value™ of 円337.87. GuruFocus considers Stella Pharma to be Fairly Valued.

Key valuation signals for TSE:4888:

  • Inventories, Raw Materials & Components: 円19.6 Mil
  • GF Value™: 円337.87 vs. price of 円337.00 (0.3% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the TSE:4888 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stella Pharma Business Description

Address 3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
74GF Score

Get the complete analysis for TSE:4888

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円337.00
Price
円337.87
GF Value